🇺🇸 FDA
Patent

US 9364462

Alpha-1-adrenergic receptor agonist therapy

granted A61KA61K31/4164

Quick answer

US patent 9364462 (Alpha-1-adrenergic receptor agonist therapy) held by The Regents of the University of California expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4164